Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price Expected to Rise, Scotiabank Analyst Says
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price upped by Scotiabank from $433.00 to $450.00 in a report published on Tuesday morning,Benzinga reports. They currently have a sector perform rating on the pharmaceutical company’s stock. Several other equities research analysts also recently commented on the stock. Citigroup started coverage on shares of Vertex […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price upped by Scotiabank from $433.00 to $450.00 in a report published on Tuesday morning,Benzinga reports. They currently have a sector perform rating on the pharmaceutical company’s stock. Several other equities research analysts also recently commented on the stock. Citigroup started coverage on shares of Vertex […]
